Adjuvant Global Health Technology Fund, L.P. - 10%+ Owner at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ANTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Adjuvant Global Health Technology Fund, L.P. - trading volume in the past year for AN2 Therapeutics, Inc.

Holdings reported by Adjuvant Global Health Technology Fund, L.P. for AN2 Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2M $38.2M $19.11 Jan 16, 2024 Direct
Common Stock 378K $7.22M $19.11 Jan 16, 2024 By Adjuvant Global Health Technology Fund DE, L.P.

Transactions reported by Adjuvant Global Health Technology Fund, L.P. for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.